title: Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment.
authors.forename: F
authors.initials: F
authors.lastname: De Keyser
authors.forename: H
authors.initials: H
authors.lastname: Mielants
authors.forename: J
authors.initials: J
authors.lastname: Praet
authors.forename: S
authors.initials: S
authors.lastname: Goemaere
authors.forename: E M
authors.initials: EM
authors.lastname: Veys
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013167:Spondylitis, Ankylosing / Q000097:blood / Q000276:immunology*; D012460:Sulfasalazine / Q000009:adverse effects*
chemical_list: D000974:Antibodies, Antinuclear; D012460:Sulfasalazine